GlobeNewswire

Nexstim Plc: Invitation to the Extraordinary General Meeting

Share

Company announcement, inside information, Helsinki, 8 February 2021 at 5.35 PM (EET)

Nexstim Plc: Invitation to the Extraordinary General Meeting

Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”) invites shareholders to the Extraordinary General Meeting of the Company to decide on authorizations for the Board of Directors to decide on share issues and issuances of option rights and special rights to shares. The Extraordinary General Meeting will be held on Monday, March 1, 2021 commencing at 1 PM (EET) at the Nexstim Headquarters, Elimäenkatu 9 B (inner court), 4th floor, 00510 Helsinki. The reception of persons who have registered for the meeting will commence at 12.30 PM (EET). Since the risk of getting infected by coronavirus is still significant, all shareholders are strongly encouraged to exercise their voting rights by proxy representation by the General Counsel of the Company. More information and instructions on authorising by proxy is available on the Company website www.nexstim.com/investors/shareholder-meetings/. Anyone with flu symptoms, who has been exposed to the coronavirus, is especially vulnerable to the virus or has travelled outside Finland 14 days prior to the General Meeting, is kindly requested not to attend the General Meeting in person. Due to the restrictions imposed by Finnish authorities, the number of participants allowed to attend the event could be limited.


A. Matters on the agenda of the Extraordinary General Meeting of Shareholders

At the Extraordinary General Meeting of Shareholders, the following matters will be considered:

1 opening of the meeting

2 calling the meeting to order

3 election of persons to scrutinize the minutes and to supervise the counting of votes

4 recording the legality of the meeting

5 recording the attendance at the meeting and adoption of the list of votes

6 Authorising the Board of Directors to decide on issuanceS of shares as well as issuanceS of option rights and other special rights entitling to shares

6.1Authorization intended to be used for future financing needs of the Company, developing the equity structure, minimize or reduce debts and possible mergers and acquisitions and other corporate purposes

The Board of Directors proposes that the Extraordinary General Meeting of Shareholders authorizes the Board of Directors to decide on share issues as well as issues of option rights and other special rights entitling to shares, pursuant to Chapter 10 of the Companies Act, as follows:

The shares issued under the authorization are new or those in the Company's possession. Based and within the limits of this authorization, the Board of Directors can also decide on issuance(s) of option rights or other special rights set forth in Chapter 10 the Limited Liability Companies Act complementing or replacing issuance(s) of shares.

Under the authorization, a maximum of two hundred twenty million (220,000,000) shares may be issued, which corresponds to approximately 33.35 percent of all the shares in the Company after the share issue, provided that new shares are issued, considering all registered shares of the Company.

In issue of new ordinary shares, the shareholders have the right to subscribe for new shares in proportion to their existing holdings of the shares of the Company. The Board of Directors has the right to decide upon the offering to parties determined by the Board of Directors of any shares that may remain unsubscribed for pursuant to the shareholders' pre-emptive subscription right. In connection with any shares which remain unsubscribed in such subscription rights issue, the Board of Directors is authorized to resolve on directed share issues or directed issues of option rights or special rights entitling to shares in deviation from the shareholders' pre-emptive right, provided that there is a weighty financial reason for the Company to do so. The shares and option rights or other special rights entitling to shares can hence be issued in one or more tranches. 

In the issuance of shares in the subscription rights issue, the Board of Directors proposes that the preliminary subscription price is EUR 0.03. Taking into account such price level, the major shareholders of the Company, Ossi Haapaniemi, Kyösti Kakkonen and Leena Niemistö each jointly with related-party companies/ book-entry accounts controlled by each, as well as certain members of the Company’s Board of Directors and management team have provided  preliminary commitments to the Company regarding subscription of new shares in such subscription rights issue with certain terms of up to approximately 48% of the authorized amount which would be equal to in aggregate approximately EUR 3,15 million.

The Board of Directors is authorized, at its discretion, to resolve the final subscription price as well as all terms for the share issues and granting of the special rights entitling to shares.

The proposed authorization does not invalidate prior resolved and registered authorizations made at the General Meeting of Shareholders regarding share issues and issuances of option rights and other special rights entitling to shares.

The authorization is valid for one (1) year from the decision of the Extraordinary General Meeting of Shareholders.

The authorization may be used for the future financing needs of the Company, developing the equity structure, minimize or reduce debts and possible mergers and acquisitions and other corporate purposes.

6.2Authorization intended to be used for the Board’s RSU plan and for the long-term incentive plans for the management and the personnel of the Company

The Board of Directors proposes that the Extraordinary General Meeting of Shareholders authorizes the Board of Directors to decide on share issues as well as issues of option rights and other special rights entitling to shares, pursuant to Chapter 10 of the Finnish Limited Liability Companies Act as follows:

The shares issued under the authorization are new or those in the Company's possession. Based and within the limits of this authorization, the Board of Directors can also decide on issuance(s) of option rights or other special rights set forth in Chapter 10 the Limited Liability Companies Act complementing or replacing issuance(s) of shares.

Under the authorization, a maximum of nineteen million five hundred thousand (19,500,000) shares may be issued, which corresponds to approximately 4.25 percent of all the shares in the Company after the share issue, provided that new shares are issued, considering all registered shares of the Company.

The shares, option rights and/or other special rights entitling to shares can be issued in one or more tranches.

The Board of Directors is authorized to resolve on all terms for the share issues and the terms for the granting of the option rights and other special rights entitling to shares. The Board of Directors is authorized to resolve on a directed share issue and issue of the special rights entitling to shares in deviation from the shareholders’ pre-emptive right, provided that there is a weighty financial reason for the Company to do so.

The proposed authorization does not invalidate prior resolved and registered authorizations made at the General Meeting of Shareholders regarding share issue, issuing of option rights and other special rights entitling to shares.

The authorization is valid for five (5) years from the decision of the Extraordinary General Meeting of Shareholders.

The authorization may be used to the implementation of the RSU plan for the members of the Board of Director’s and for the long-term incentive plans for the management and the personnel of the Company. The authorization can also be used for incentive arrangements and payment of the Board fees.

6.3Authorization intended to be used for future financing needs of the Company, developing the equity structure, minimize or reduce debts and possible mergers and acquisitions and other corporate purposes

The Board of Directors proposes that the Extraordinary General Meeting of Shareholders authorizes the Board of Directors to decide on share issues as well as issues of option rights and other special rights entitling to shares, pursuant to Chapter 10 of the Finnish Limited Liability Companies Act as follows:

The shares issued under the authorization are new or those in the Company's possession. Based and within the limits of this authorization, the Board of Directors can also decide on issuance(s) of option rights or other special rights set forth in Chapter 10 the Limited Liability Companies Act complementing or replacing issuance(s) of shares.

Under the authorization, a maximum of five million (5,000,000) shares may be issued, which corresponds to approximately 1.12 percent of all the shares in the Company after the share issue, provided that new shares are issued, considering all registered shares of the Company.

The shares, option rights and/or other special rights entitling to shares can be issued in one or more tranches.

The Board of Directors is authorized to resolve on all terms for the share issues and the terms for the granting of the option rights and other special rights entitling to shares. The Board of Directors is authorized to resolve on a directed share issue and issue of the special rights entitling to shares in deviation from the shareholders’ pre-emptive right, provided that there is a weighty financial reason for the Company to do so. Such new shares may also be issued without payment, provided that there as a particularly weighty financial reason for the Company and considering the interests of its all shareholders to do so.

The proposed authorization does not invalidate prior resolved and registered authorizations made at the General Meeting of Shareholders regarding share issue, issuing of option rights and other special rights entitling to shares.

The authorization is valid for one (1) year from the decision of the Annual General Meeting of Shareholders.

The authorization may be used in connection with future financing needs of the Company (e.g. for a payment of fee payable in Nexstim shares for an investor providing a significant subscription commitment in connection with a possible share issue), developing the equity structure, minimize or reduce debts and possible mergers and acquisitions and other corporate purposes.

7  CLOSING OF THE MEETING


B. Documents of the General Meeting of Shareholders

The proposals of the Board of Directors and other documents set forth in Chapter 5 Section 21 of the Finnish Act on Limited Liability Companies (21.6.2006/624, as amended) as well as this notice are available on Nexstim Plc’s website at www.nexstim.com/investors/shareholder-meetings/ no later than on 8 February 2021 (as printable PDFs files). Such documents are also available at the General Meeting. The minutes of the meeting will be available on the above-mentioned website as from March 15, 2021 at the latest.


C. Instructions for the participants in the Extraordinary General Meeting of Shareholders

1. Shareholders registered in the shareholders’ register

Each shareholder, who is registered on February 17, 2021 in the shareholders’ register of the Company held by Euroclear Finland Ltd, has the right to participate in the Extraordinary General Meeting of Shareholders. A shareholder, whose shares are registered on his/her personal book-entry account, is registered in the shareholders’ register of the Company.

A shareholder, who wants to participate in the Extraordinary General Meeting of Shareholders, shall register for the meeting no later than February 24, 2021  at 10.00 a.m. by giving a prior notice of participation. Such notice can be given:

  1. on the Company’s website: https://nexstim.com/investors/shareholder-meetings/  ; or
  2. by mail to address Nexstim Plc, “Extraordinary General Meeting” Elimäenkatu 9B, 00510 Helsinki, Finland

In connection with the registration, a shareholder shall notify his/her name, personal identification number or business ID, address, telephone number and the name of a possible assistant or proxy representative. The personal data given to Nexstim Plc is used only in connection with the General Meeting of Shareholders and with the processing of related registrations.

2. Holders of nominee registered shares

A holder of nominee registered shares has the right to participate in the Extraordinary General Meeting by virtue of such shares, based on which he/she on the record date of the Extraordinary General Meeting, i.e. on February 17, 2021, would be entitled to be registered in the shareholders’ register of the Company held by Euroclear Finland Ltd. The right to participate in the General Meeting requires, in addition, that the shareholder on the basis of such shares has been registered into the temporary shareholders’ register held by Euroclear Finland Ltd at the latest by February 24, 2021 at 10.00 a.m. As regards nominee registered shares this constitutes due registration for the General Meeting.

A holder of nominee registered shares is advised to request without delay necessary instructions regarding the registration in the shareholders’ register of the Company, the issuing of proxy documents and registration for the Extraordinary General Meeting of Shareholders from his/her custodian bank. The account management organization of the custodian bank has to register a holder of nominee registered shares, who wants to participate in the Extraordinary General Meeting, into the temporary shareholders’ register of the Company at the latest by the time stated above.

3. Shares registered in Euroclear Sweden AB

A shareholder with shares registered in Euroclear Sweden AB´s Securities System who wishes to attend and vote at the Extraordinary General Meeting must:

  • be registered in the shareholders’ register maintained by Euroclear Sweden AB no later than on 16 February 2021.
  • Shareholders, whose shares are registered in the name of a nominee must, in order to be eligible to request a temporary registration in the shareholders’ register of Nexstim Plc maintained by Euroclear Finland, request that their shares are re-registered in their own names in the register of shareholders maintained by Euroclear Sweden AB, and procure that the nominee sends the above mentioned request for temporary registration to Euroclear Sweden AB on their behalf. Such registration must be made at the latest by 16 February 2021 and the nominee should therefore be notified well in advance before said date.
  • request temporary registration in the shareholders’ register of Nexstim Plc maintained by Euroclear Finland Oy. Such request shall be submitted in writing to Euroclear Sweden AB no later than on 16 February 2021 at 5 p.m. Swedish time.

This temporary registration made through written request to Euroclear Sweden AB is considered a notice of attendance at the General Meeting.

4. Proxy representative and powers of attorney

A shareholder may participate in the Extraordinary General Meeting of Shareholders and exercise his/her rights at the Meeting by way of proxy representation. A proxy representative shall produce a dated proxy document or otherwise in a reliable manner demonstrate his/her right to represent the shareholder at the Extraordinary General Meeting of Shareholders.

When a shareholder participates in the Extraordinary General Meeting of Shareholders by means of several proxy representatives representing the shareholder with shares at different securities accounts, the shares by which each proxy representative represents the shareholder shall be identified in connection with the registration for the Extraordinary General Meeting of Shareholders.

Possible proxy documents should be delivered in originals to Nexstim Plc, “Extraordinary General Meeting” Elimäenkatu 9 B, 00510 Helsinki, Finland before the last date for registration.

5. Other instructions and information

Pursuant to chapter 5, section 25 of the Companies Act, a shareholder who is present at the General Meeting has the right to request information with respect to the matters to be considered at the Meeting.

The meeting will be conducted in Finnish language. Part of the material presented at the meeting may be in English language.

On the date of this notice to the Extraordinary General Meeting of Shareholders, dated February 8, 2021, the total number of shares and votes in Nexstim Plc is 439,622,756.


Helsinki, February 8, 2021

NEXSTIM PLC

The Board of Directors


Further information is available on the website www.nexstim.com, or by contacting:

Leena Niemistö, Chairman
+358 9 2727 170
leena.niemisto@nexstim.com

Erik Penser Bank AB (Certified Adviser)                        
 +46 8 463 83 00
certifiedadviser@penser.se


About Nexstim Plc

Nexstim is a Finnish, globally operating medical technology company. Our mission is to enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders.

Nexstim has developed a world-leading non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain.

SmartFocus® technology is used in Nexstim’s proprietary Navigated Brain Therapy (NBT®) system, which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States. In Europe, the NBT® system is CE marked for the treatment of major depression and chronic neuropathic pain.

In addition, Nexstim is commercializing its SmartFocus® based Navigated Brain Stimulation (NBS) system for diagnostic applications. The NBS system is the only FDA cleared and CE marked navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain. Nexstim shares are listed on the Nasdaq First North Growth Market Finland and Nasdaq First North Growth Market Sweden.

For more information please visit www.nexstim.com

Attachment


About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

RESULT OF RIKSBANK REVERSED AUCTIONS SEK MUNICIPAL BONDS9.3.2021 11:30:00 CETPress release

AuctionAuction resultsAuction date2021-03-09Maturity2024Tendered volume, SEK mln1000 +/- 1000Offered volume, SEK mln700Volume bought, SEK mln200Number of bids3Number of accepted bids2 QuarterQuarter 1Quarter 2Quarter 3Quarter 4Offered volume, SEK mln05000100Volume bought, SEK mln000100Number of bids0101Number of accepted bids0001Average yield, %---0.18Lowest accepted yield, %---0.18Highest yield, %---0.18Accepted at lowest yield, %---100 QuarterQuarter 1Quarter 2Quarter 3Quarter 4Offered volume, SEK mln010000Volume bought, SEK mln010000Number of bids0100Number of accepted bids0100Average yield, %-0.137--Lowest accepted yield, %-0.137--Highest yield, %-0.137--Accepted at lowest yield, %-100--

Results Extraordinary General Meeting9.3.2021 08:30:00 CETPress release

PRESS RELEASE: Amsterdam – 9 March 2021.Intertrust N.V. (“Intertrust”) [Euronext: INTER], a global leader in providing tech-enabled corporate and fund solutions to clients operating and investing in international business, announces that in the Extraordinary General Meeting (EGM) of 8 March 2021 the shareholders adopted all voting items on the agenda. Chief Executive Officer Shankar Iyer was appointed as member of the Management Board of Intertrust. Mr. Iyer’s appointment has been approved by Dutch regulators and is effective immediately, for a first term of four years. At the EGM a total of 74.32% of the total issued share capital was represented. The results of the votes for each item on the agenda, will be published on our website https://www.intertrustgroup.com/investors/shareholder-information/extraordinary-general-meeting-march-2021/. Draft minutes of the EGM will be published no later than three months after the end of the meeting, after which shareholders should have the opport

Van Lanschot Kempen: update on share buy-back programme 2 March 2021 – 8 March 20219.3.2021 08:30:00 CETPress release

Amsterdam/’s-Hertogenbosch, the Netherlands, 9 March 2021 In the period from 2 March 2021 until 8 March 2021 Van Lanschot Kempen has repurchased 16,381 of its own shares (depositary receipts for Class A ordinary shares). The shares were repurchased at an average price of €21.80 per share for a total amount of €358,433. These repurchases are part of the share buy-back programme for at most 400,000 of own shares, which was announced on 25 February 2021. The total number of shares repurchased to date is 41,381. More information, including a detailed overview of the repurchase transactions under this programme, is available on www.vanlanschotkempen.com/sharebuyback. Media Relations: +31 20 354 45 85; mediarelations@vanlanschotkempen.com Investor Relations: +31 20 354 45 90; investorrelations@vanlanschotkempen.com About Van Lanschot Kempen Van Lanschot Kempen, a wealth manager operating under the Van Lanschot, Kempen and Evi brand names, is active in Private Banking, Asset Management and Me

GrandVision publishes Annual Report 2020 and convocation for virtual AGM9.3.2021 08:00:00 CETPress release

GrandVision publishes Annual Report 2020 and convocation for virtual AGM Schiphol, the Netherlands - 9 March 2021. GrandVision N.V. (EURONEXT: GVNV) today announced that it has published its Annual Report 2020 including the Financial Statements 2020. The Annual Report is available for download and in digital form on GrandVision’s website: annualreport2020.grandvision.com. GrandVision has also published the convocation for the Annual General Meeting of Shareholders (AGM) on its website (www.grandvision.com). The AGM will be held on 23 April 2020. Due to the continued impact of the COVID-19 pandemic, the meeting will be held virtually, and shareholders will not be able to attend the AGM in person at a physical location. By using this format, GrandVision is following recommendations to forgo major events and to protect the health of shareholders, employees and all other stakeholders. Details of how shareholders can exercise their shareholder rights under these special circumstances are se

Kalmar receives repeat order of AutoStrads from Patrick Terminals9.3.2021 08:00:00 CETPress release

CARGOTEC CORPORATION, PRESS RELEASE, 9 MARCH 2021 AT 9 AM (EET) Kalmar, part of Cargotec, is to supply a total of twelve new Kalmar AutoStrad™ units to Patrick Terminals. The order for the fully automated straddle carriers was booked in Cargotec's 2021 Q1 order intake, with delivery of the machines scheduled to be completed during Q2 of 2022. Patrick Terminals is Australia's leading container terminal operator, handling over three million TEUs annually. The company operates some of Australia's most technologically advanced terminals at four strategically located ports: Brisbane AutoStrad Terminal, Sydney AutoStrad Terminal, Melbourne Terminal and Fremantle Terminal in Western Australia. In November 2019 Patrick Terminals signed a comprehensive software maintenance and support agreement with Kalmar covering the equipment automation systems at Brisbane and Sydney. Of the twelve new 8th generation Kalmar AutoStrads, five will operate at Brisbane and seven at Sydney. The machines are part

Ahold Delhaize share buyback update9.3.2021 08:00:00 CETPress release

Zaandam, the Netherlands, March 9, 2021 – Ahold Delhaize has repurchased 1,693,300 of Ahold Delhaize common shares in the period from March 1, 2021 up to and including March 5, 2021. The shares were repurchased at an average price of €21.93 per share for a total consideration of € 37.1 million. These repurchases were made as part of the €1 billion share buyback program announced on November 4, 2020. The total number of shares repurchased under this program to date is 11,368,600 common shares for a total consideration of € 262.9 million. Download the share buyback transactions excel sheet for detailed individual transaction information from www.aholddelhaize.com/en/investors/share-information/share-buy-back-programs/ This press release is issued in connection with the disclosure and reporting obligation set out in Article 2(2) of the EU Regulation that contains technical standards for buyback programs.